These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30090101)

  • 1.
    Campos MP; Figueiredo FB; Morgado FN; Renzetti ARDS; de Souza SMM; Pereira SA; Rodrigues-Da-Silva RN; Lima-Junior JDC; De Luca PM
    Front Immunol; 2018; 9():1690. PubMed ID: 30090101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population.
    Testasicca MC; dos Santos MS; Machado LM; Serufo AV; Doro D; Avelar D; Tibúrcio AM; Abrantes Cde F; Machado-Coelho GL; Grimaldi G; Gazzinelli RT; Fernandes AP
    Vet Parasitol; 2014 Aug; 204(3-4):169-76. PubMed ID: 24863572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.
    Lage DP; Martins VT; Duarte MC; Costa LE; Garde E; Dimer LM; Kursancew AC; Chávez-Fumagalli MA; de Magalhães-Soares DF; Menezes-Souza D; Roatt BM; Machado-de-Ávila RA; Soto M; Tavares CA; Coelho EA
    Parasitol Res; 2016 Apr; 115(4):1649-58. PubMed ID: 26782811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis.
    Fernandes CB; Junior JT; de Jesus C; Souza BM; Larangeira DF; Fraga DB; Tavares Veras PS; Barrouin-Melo SM
    Vaccine; 2014 Mar; 32(11):1287-95. PubMed ID: 24406392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field randomized trial to evaluate the efficacy of the Leish-Tec® vaccine against canine visceral leishmaniasis in an endemic area of Brazil.
    Regina-Silva S; Feres AM; França-Silva JC; Dias ES; Michalsky ÉM; de Andrade HM; Coelho EA; Ribeiro GM; Fernandes AP; Machado-Coelho GL
    Vaccine; 2016 Apr; 34(19):2233-9. PubMed ID: 26997002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field trial of efficacy of the Leish-tec® vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    Grimaldi G; Teva A; Dos-Santos CB; Santos FN; Pinto ID; Fux B; Leite GR; Falqueto A
    PLoS One; 2017; 12(9):e0185438. PubMed ID: 28953944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of recombinant proteins in diagnosis and differentiation of canine visceral leishmaniasis infected and vaccinated dogs.
    Pereira IE; Silva KP; Menegati LM; Pinheiro AC; Assunção EAO; Araújo MLP; Abass E; Duthie MS; Steinhoff U; Teixeira HC
    Eur J Microbiol Immunol (Bp); 2020 Aug; 10(3):165-171. PubMed ID: 32857712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis.
    Menezes-Souza D; Mendes TA; Nagem RA; Santos TT; Silva AL; Santoro MM; de Carvalho SF; Coelho EA; Bartholomeu DC; Fujiwara RT
    PLoS One; 2014; 9(6):e99216. PubMed ID: 24921246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum:
    Campos MP; Figueiredo FB; Morgado FN; Renzetti ARDS; de Souza SMM; Pereira SA; Rodrigues-Da-Silva RN; Lima-Junior JDC; De Luca PM
    Front Immunol; 2018; 9():2245. PubMed ID: 30349528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
    Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA
    Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®.
    Marcondes M; de Lima VM; de Araújo Mde F; Hiramoto RM; Tolezano JE; Vieira RF; Biondo AW
    Vet Parasitol; 2013 Nov; 197(3-4):649-52. PubMed ID: 23920056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
    de Andrade RA; Reis AB; Gontijo CM; Braga LB; Rocha RD; Araújo MS; Vianna LR; Martins-Filho OA
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):85-97. PubMed ID: 17287029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass profile of serum antibodies to Leishmania chagasi in naturally infected and vaccinated dogs.
    Oliveira TM; Mineo TW; Bason M; Day MJ; Machado RZ
    Vet Parasitol; 2009 May; 162(1-2):16-22. PubMed ID: 19345019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
    Coelho EA; Costa LE; Lage DP; Martins VT; Garde E; de Jesus Pereira NC; Lopes EG; Borges LF; Duarte MC; Menezes-Souza D; de Magalhães-Soares DF; Chávez-Fumagalli MA; Soto M; Tavares CA
    Vet Parasitol; 2016 Jan; 215():63-71. PubMed ID: 26790739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the DPP(®) CVL rapid test for canine serodiagnosis in area of visceral leishmaniasis.
    Laurenti MD; de Santana Leandro MV; Tomokane TY; De Lucca HR; Aschar M; Souza CS; Silva RM; Marcondes M; da Matta VL
    Vet Parasitol; 2014 Oct; 205(3-4):444-50. PubMed ID: 25257505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.
    de Mendonça LZ; Resende LA; Lanna MF; Aguiar-Soares RD; Roatt BM; Castro RA; Batista MA; Silveira-Lemos D; Gomes Jde A; Fujiwara RT; Rezende SA; Martins-Filho OA; Corrêa-Oliveira R; Dutra WO; Reis AB; Giunchetti RC
    Parasit Vectors; 2016 Aug; 9(1):472. PubMed ID: 27577735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal IgG subclasses response in dogs following vaccination against Leishmania with Leishmune®.
    Marcondes M; Ikeda FA; Vieira RF; Day MJ; Lima VM; Rossi CN; Perri SH; Biondo AW
    Vet Parasitol; 2011 Sep; 181(2-4):153-9. PubMed ID: 21530083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine visceral leishmaniasis follow-up: a new anti-IgG serological test more sensitive than ITS-1 conventional PCR.
    Faria AR; Pires SDF; Reis AB; Coura-Vital W; Silveira JAGD; Sousa GM; Bueno MLC; Gazzinelli RT; Andrade HM
    Vet Parasitol; 2017 Dec; 248():62-67. PubMed ID: 29173543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.